A Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Rilvegostomig in Adult Participants With Advanced Solid Tumors Previously Treated With Standard of Care Therapy
Clinical trial NCT07161414 · RECRUITING
Trial details
- NCT number
- NCT07161414
- Sponsor
- AstraZeneca
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-25
- Primary completion
- 2027-07-19
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.